Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 5/2004

01-05-2004 | Original Paper

Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors

Authors: B. Böhm, M. Voth, J. Geoghegan, H. Hellfritzsch, A. Petrovich, J. Scheele, D. Gottschild

Published in: Journal of Cancer Research and Clinical Oncology | Issue 5/2004

Login to get access

Abstract

Purpose

Outcome of patients with metastatic disease mainly depends on accurate preoperative tumor staging. 18[F]fluorodeoxyglucose positron emission tomography (18F-PET) has been proven to be a valuable diagnostic tool in a number of different tumors but its direct influence on liver surgery has not been thoroughly investigated.

Materials and methods

Between July 1999 and March 2000, 50 consecutive patients with 174 suspected liver lesions were admitted to the University Hospital Jena. All 50 patients underwent abdominal ultrasound, CT-scan, and 18-FDG positron emission tomography scanning. In 23 patients the diagnostic work-up was completed by MRI scan.

Results

Altogether there were a total of 174 histologically proven intrahepatic lesions, nine of which were benign. The sensitivity, specificity, and positive predictive value of PET for all hepatic lesions was 82%, 25%, and 96% compared with 63%, 50%, and 96% for abdominal ultrasound, 71%, 50%, and 97% for CT-scan, and 83%, 57%, and 97% for MRI-scan. In 23 of 50 patients 24 extrahepatic lesions were identified. In these patients the sensitivity and specificity of PET—compared to abdominal ultrasound, CT-scan, and MRI-scan for all extrahepatic lesions—was 63% and 60%, 29% and 25%, 47% and 50% and 40% and 50%, respectively. The findings on PET scan had a direct impact on operative management in nine patients (18%).

Conclusions

Our series demonstrates good sensitivity and specificity for the detection of primary and secondary liver lesions which is superior to ultrasound and CT scan but not to MRI scan. The main value of PET scan consists in the detection of extrahepatic tumor (64%). Due to better detection of extrahepatic tumor, FDG-PET is a very useful addition to the currently used anatomically-based images in all cases of advanced tumor spread with high risk of extrahepatic tumor.
Literature
1.
go back to reference Boykin KN, Zibari GB, Lilien DL, McMillan RW, Aultman DF, McDonald JC (1999) The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver. Am Surg 65:1183–1185PubMed Boykin KN, Zibari GB, Lilien DL, McMillan RW, Aultman DF, McDonald JC (1999) The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver. Am Surg 65:1183–1185PubMed
2.
go back to reference Fong Y, Saldinger PF, Akhurst T, Macapinlac H, Yeung H, Finn RD, Cohen A, Kemeny N, Blumgart LH, Larson SM (1999) Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg 178:282–287CrossRefPubMed Fong Y, Saldinger PF, Akhurst T, Macapinlac H, Yeung H, Finn RD, Cohen A, Kemeny N, Blumgart LH, Larson SM (1999) Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg 178:282–287CrossRefPubMed
3.
go back to reference Delbeke D, Vitola JV, Sandler MP, Arildsen RC, Powers TA, Wright JK Jr, Chapman WC, Pinson CW (1997) Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med 38:1196–1201PubMed Delbeke D, Vitola JV, Sandler MP, Arildsen RC, Powers TA, Wright JK Jr, Chapman WC, Pinson CW (1997) Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med 38:1196–1201PubMed
4.
go back to reference Ogunbiyi OA, Flanagan FL, Dehdashti F, Siegel BA, Trask DD, Birnbaum EH, Fleshman JW, Read TE, Philpott GW, Kodner IJ (1997) Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography. Ann Surg Oncol 4:613–620PubMed Ogunbiyi OA, Flanagan FL, Dehdashti F, Siegel BA, Trask DD, Birnbaum EH, Fleshman JW, Read TE, Philpott GW, Kodner IJ (1997) Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography. Ann Surg Oncol 4:613–620PubMed
5.
go back to reference Lewis PJ, Salama A (1994) Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med 35:1647–1649PubMed Lewis PJ, Salama A (1994) Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med 35:1647–1649PubMed
6.
go back to reference Lai DT, Fulham M, Stephen MS, Chu KM, Solomon M, Thompson JF, Sheldon DM, Storey DW (1996) The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. Arch Surg 131:703–707PubMed Lai DT, Fulham M, Stephen MS, Chu KM, Solomon M, Thompson JF, Sheldon DM, Storey DW (1996) The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. Arch Surg 131:703–707PubMed
7.
go back to reference Hughes KS, Simon R, Songhorabodi S, Adson MA, Ilstrup DM, Fortner JG, Maclean BJ, Foster JH, Daly JM, Fitzherbert D (1986) Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 100:278–284PubMed Hughes KS, Simon R, Songhorabodi S, Adson MA, Ilstrup DM, Fortner JG, Maclean BJ, Foster JH, Daly JM, Fitzherbert D (1986) Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 100:278–284PubMed
8.
go back to reference Fortner JG, Silva JS, Golbey RB, Cox EB, Maclean BJ (1984) Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg 199:306–316PubMed Fortner JG, Silva JS, Golbey RB, Cox EB, Maclean BJ (1984) Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg 199:306–316PubMed
9.
go back to reference August DA, Sugarbaker PH, Ottow RT, Gianola FJ, Schneider PD (1985) Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intraperitoneal 5-fluorouracil via Tenckhoff catheter on survival. Ann Surg 201:210–218PubMed August DA, Sugarbaker PH, Ottow RT, Gianola FJ, Schneider PD (1985) Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intraperitoneal 5-fluorouracil via Tenckhoff catheter on survival. Ann Surg 201:210–218PubMed
10.
go back to reference Fischman AJ (1996) Positron emission tomography in the clinical evaluation of metastatic cancer. J Clin Oncol 14:691–696PubMed Fischman AJ (1996) Positron emission tomography in the clinical evaluation of metastatic cancer. J Clin Oncol 14:691–696PubMed
11.
go back to reference Collins BT, Lowe VJ, Dunphy FR (1999) Correlation of CT-guided fine-needle aspiration biopsy of the liver with fluoride-18 fluorodeoxyglucose positron emission tomography in the assessment of metastatic hepatic abnormalities. Diagn Cytopathol 21:39–42CrossRefPubMed Collins BT, Lowe VJ, Dunphy FR (1999) Correlation of CT-guided fine-needle aspiration biopsy of the liver with fluoride-18 fluorodeoxyglucose positron emission tomography in the assessment of metastatic hepatic abnormalities. Diagn Cytopathol 21:39–42CrossRefPubMed
12.
go back to reference Lowe VJ, Fletcher JW, Gobar L, Lawson M, Kirchner P, Valk P, Karis J, Hubner K, Delbeke D, Heiberg EV, Patz EF, Coleman RE (1998) Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol 16:1075–1084PubMed Lowe VJ, Fletcher JW, Gobar L, Lawson M, Kirchner P, Valk P, Karis J, Hubner K, Delbeke D, Heiberg EV, Patz EF, Coleman RE (1998) Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol 16:1075–1084PubMed
13.
go back to reference Pasquali C, Rubello D, Sperti C, Gasparoni P, Liessi G, Chierichetti F, Ferlin G, Pedrazzoli S (1998) Neuroendocrine tumor imaging: can 18F-fluorodeoxyglucose positron emission tomography detect tumors with poor prognosis and aggressive behavior? World J Surg 22:588–592CrossRefPubMed Pasquali C, Rubello D, Sperti C, Gasparoni P, Liessi G, Chierichetti F, Ferlin G, Pedrazzoli S (1998) Neuroendocrine tumor imaging: can 18F-fluorodeoxyglucose positron emission tomography detect tumors with poor prognosis and aggressive behavior? World J Surg 22:588–592CrossRefPubMed
14.
go back to reference Wong WL, Chevretton EB, McGurk M, Hussain K, Davis J, Beaney R, Baddeley H, Tierney P, Maisey M (1997) A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma. Clin Otolaryngol 22:209–214PubMed Wong WL, Chevretton EB, McGurk M, Hussain K, Davis J, Beaney R, Baddeley H, Tierney P, Maisey M (1997) A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma. Clin Otolaryngol 22:209–214PubMed
15.
go back to reference Moss AA (1989) Imaging of colorectal carcinoma. Radiology 170:308–310PubMed Moss AA (1989) Imaging of colorectal carcinoma. Radiology 170:308–310PubMed
16.
go back to reference Flier JS, Mueckler MM, Usher P, Lodish HF (1987) Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 235:1492–1495PubMed Flier JS, Mueckler MM, Usher P, Lodish HF (1987) Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 235:1492–1495PubMed
17.
go back to reference Monakhov NK, Neistadt EL, Shavlovskil MM, Shvartsman AL, Neifakh SA (1978) Physicochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues. J Natl Cancer Inst 61:27–34PubMed Monakhov NK, Neistadt EL, Shavlovskil MM, Shvartsman AL, Neifakh SA (1978) Physicochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues. J Natl Cancer Inst 61:27–34PubMed
18.
go back to reference Reske SN (1999) Current status of positron emission tomography in diagnosis of abdominal tumors. Schweiz Rundsch Med Prax 88:52–58PubMed Reske SN (1999) Current status of positron emission tomography in diagnosis of abdominal tumors. Schweiz Rundsch Med Prax 88:52–58PubMed
19.
go back to reference Kurtaran A, Becherer A, Pfeffel F, Muller C, Traub T, Schmaljohann J, Kaserer K, Raderer M, Schima W, Dudcak R, Kletter K, Virgolini I (2000) 18F-fluorodeoxyglucose (FDG)-PET features of focal nodula hyperplasia (FNH) of the liver. Liver 20:487–490CrossRefPubMed Kurtaran A, Becherer A, Pfeffel F, Muller C, Traub T, Schmaljohann J, Kaserer K, Raderer M, Schima W, Dudcak R, Kletter K, Virgolini I (2000) 18F-fluorodeoxyglucose (FDG)-PET features of focal nodula hyperplasia (FNH) of the liver. Liver 20:487–490CrossRefPubMed
20.
go back to reference Frohlich A, Diederichs CG, Staib L, Vogel J, Beger HG, Reske SN (1999) Detection of liver metastases from pancreatic cancer using FDG-PET. J Nucl Med 40:250–255 Frohlich A, Diederichs CG, Staib L, Vogel J, Beger HG, Reske SN (1999) Detection of liver metastases from pancreatic cancer using FDG-PET. J Nucl Med 40:250–255
21.
go back to reference Trojan J, Schroeder O, Raedle J, Baum RP, Herrmann G, Jacobi V, Zeuzem S (1999) Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Am J Gastroenterol 94:3314–3319CrossRefPubMed Trojan J, Schroeder O, Raedle J, Baum RP, Herrmann G, Jacobi V, Zeuzem S (1999) Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Am J Gastroenterol 94:3314–3319CrossRefPubMed
22.
go back to reference Iwata Y, Shiomi S, Sasaki N, Jomura H, Nishiguchi S, Seki S, Kawabe J, Ochi H (2000) Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors. Ann Nucl Med 14:121–126 Iwata Y, Shiomi S, Sasaki N, Jomura H, Nishiguchi S, Seki S, Kawabe J, Ochi H (2000) Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors. Ann Nucl Med 14:121–126
23.
go back to reference Khan MA, Combs CS, Brunt EM, Lowe VJ, Wolverson MK, Solomon H, Collins BT, Di Bisceglie AM (2000) Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol 32:792–797CrossRefPubMed Khan MA, Combs CS, Brunt EM, Lowe VJ, Wolverson MK, Solomon H, Collins BT, Di Bisceglie AM (2000) Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol 32:792–797CrossRefPubMed
24.
go back to reference Jadvar H, Segall GM (1997) False-negative fluorine-18-FDG PET in metastatic carcinoid. J Nucl Med 38:1382–1383 Jadvar H, Segall GM (1997) False-negative fluorine-18-FDG PET in metastatic carcinoid. J Nucl Med 38:1382–1383
25.
go back to reference Moehler M, Dimitrakopoulou-Strauss A, Gutzler F, Raeth U, Strauss LG, Stremmel W (1998) 18F-labeled fluorouracil positron emission tomography and the prognoses of colorectal carcinoma patients with metastases to the liver treated with 5-fluorouracil. Cancer 83:245–253PubMed Moehler M, Dimitrakopoulou-Strauss A, Gutzler F, Raeth U, Strauss LG, Stremmel W (1998) 18F-labeled fluorouracil positron emission tomography and the prognoses of colorectal carcinoma patients with metastases to the liver treated with 5-fluorouracil. Cancer 83:245–253PubMed
26.
go back to reference Scheele J, Stangl R, Altendorf-Hofmann A (1990) Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77:1241–1246PubMed Scheele J, Stangl R, Altendorf-Hofmann A (1990) Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77:1241–1246PubMed
28.
go back to reference Vitola JV, Delbeke D, Meranze SG, Mazer MJ, Pinson CW (1996) Positron emission tomography with F-18-fluorodeoxyglucose to evaluate the results of hepatic chemoembolization. Cancer 1578:2216–2222CrossRef Vitola JV, Delbeke D, Meranze SG, Mazer MJ, Pinson CW (1996) Positron emission tomography with F-18-fluorodeoxyglucose to evaluate the results of hepatic chemoembolization. Cancer 1578:2216–2222CrossRef
29.
go back to reference Dimitrakopoulou-Strauss A, Strauss LG, Schlag P, Hohenberger P, Mohler M, Oberdorfer F, van Kaick G (1998) Fluorine-18-fluorouracil to predict therapy response in liver metastases from colorectal carcinoma. J Nucl Med 39:1197–1202PubMed Dimitrakopoulou-Strauss A, Strauss LG, Schlag P, Hohenberger P, Mohler M, Oberdorfer F, van Kaick G (1998) Fluorine-18-fluorouracil to predict therapy response in liver metastases from colorectal carcinoma. J Nucl Med 39:1197–1202PubMed
30.
go back to reference Widjaja A, Mix H, Wagner S, Graz KF, van den Hoff J, Petrich T, Meier PN, Manns MP (1999) Positron emission tomography and cholangiocarcinoma in primary sclerosing cholangitis. Z Gastroenterol 37:731–733PubMed Widjaja A, Mix H, Wagner S, Graz KF, van den Hoff J, Petrich T, Meier PN, Manns MP (1999) Positron emission tomography and cholangiocarcinoma in primary sclerosing cholangitis. Z Gastroenterol 37:731–733PubMed
32.
go back to reference Frohlich A, Diederichs CG, Staib L, Vogel J, Beger HG, Reske SN (1999) Detection of liver metastases from pancreatic cancer using FDG PET. J Nucl Med 40:250–255 Frohlich A, Diederichs CG, Staib L, Vogel J, Beger HG, Reske SN (1999) Detection of liver metastases from pancreatic cancer using FDG PET. J Nucl Med 40:250–255
33.
go back to reference Patel PM, Alibazoglu H, Ali A, Fordham E, LaMonica G (1997) False-positive’ uptake of FDG in a hepatic adenoma. Clin Nucl Med 22:490–491CrossRefPubMed Patel PM, Alibazoglu H, Ali A, Fordham E, LaMonica G (1997) False-positive’ uptake of FDG in a hepatic adenoma. Clin Nucl Med 22:490–491CrossRefPubMed
34.
go back to reference Schluter B, Grimm-Riepe C, Beyer W, Lubeck M, Schirren-Bumann K, Clausen M (1998) Histological verification of positive fluorine-18 fluorodeoxyglucose findings in patients with differentiated thyroid cancer. Langenbecks Arch Surg 383:187–189PubMed Schluter B, Grimm-Riepe C, Beyer W, Lubeck M, Schirren-Bumann K, Clausen M (1998) Histological verification of positive fluorine-18 fluorodeoxyglucose findings in patients with differentiated thyroid cancer. Langenbecks Arch Surg 383:187–189PubMed
35.
go back to reference Dimitrakopoulou-Strauss A, Strauss LG, Goldschmidt H, Lorenz WJ, Maier-Borst W, van Kaick G (1995) Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas. Eur J Nucl Med 22:434–442PubMed Dimitrakopoulou-Strauss A, Strauss LG, Goldschmidt H, Lorenz WJ, Maier-Borst W, van Kaick G (1995) Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas. Eur J Nucl Med 22:434–442PubMed
36.
go back to reference Findlay M, Young H, Cunningham D, Iveson A, Cronin B, Hickish T, Pratt B, Husband J, Flower M, Ott R (1996) Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. J Clin Oncol 14:700–708PubMed Findlay M, Young H, Cunningham D, Iveson A, Cronin B, Hickish T, Pratt B, Husband J, Flower M, Ott R (1996) Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. J Clin Oncol 14:700–708PubMed
37.
go back to reference Torizuka T, Tamaki N, Inokuma T, Magata Y, Yonekura Y, Tanaka A, Yamaoka Y, Yamamoto K, Konishi J (1994) Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy. J Nucl Med. 35:1965–1969 Torizuka T, Tamaki N, Inokuma T, Magata Y, Yonekura Y, Tanaka A, Yamaoka Y, Yamamoto K, Konishi J (1994) Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy. J Nucl Med. 35:1965–1969
38.
go back to reference Kubota K, Matsuzawa T, Fujiwara T, Ito M, Hatazawa J, Ishiwata K, Iwata R, Ido T (1990) Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med 31:1927–1932PubMed Kubota K, Matsuzawa T, Fujiwara T, Ito M, Hatazawa J, Ishiwata K, Iwata R, Ido T (1990) Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med 31:1927–1932PubMed
39.
go back to reference Minn H, Lapela M, Klemi PJ, Grenman R, Leskinen S, Lindholm P, Bergman J, Eronen E, Haaparanta M, Joensuu H (1997) Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. J Nucl Med 38:1907–1911PubMed Minn H, Lapela M, Klemi PJ, Grenman R, Leskinen S, Lindholm P, Bergman J, Eronen E, Haaparanta M, Joensuu H (1997) Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. J Nucl Med 38:1907–1911PubMed
40.
go back to reference Schirrmeister H, Kuhn T, Guhlmann A, Santjohanser C, Horster T, Nussle K, Koretz K, Glatting G, Rieber A, Kreienberg R, Buck AC, Reske SN (2001) Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures. Eur J Nucl Med 28:351–358 Schirrmeister H, Kuhn T, Guhlmann A, Santjohanser C, Horster T, Nussle K, Koretz K, Glatting G, Rieber A, Kreienberg R, Buck AC, Reske SN (2001) Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures. Eur J Nucl Med 28:351–358
41.
go back to reference Rostom AY, Powe J, Kandil A, Ezzat A, Bakheet S, el-Khwsky F, el-Hussainy G, Sorbris R, Sjoklint O (1999) Positron emission tomography in breast cancer: a clinicopathological correlation of results. Br J Radiol 72:1064–1068PubMed Rostom AY, Powe J, Kandil A, Ezzat A, Bakheet S, el-Khwsky F, el-Hussainy G, Sorbris R, Sjoklint O (1999) Positron emission tomography in breast cancer: a clinicopathological correlation of results. Br J Radiol 72:1064–1068PubMed
42.
go back to reference Grab D, Flock F, Stohr I, Nussle K, Rieber A, Fenchel S, Brambs HJ, Reske SN, Kreienberg R (2000) Classification of asymptomatic adnexal masses by ultrasound, magnetic resonance imaging, and positron emission tomography. Gynecol Oncol 77:454–459CrossRefPubMed Grab D, Flock F, Stohr I, Nussle K, Rieber A, Fenchel S, Brambs HJ, Reske SN, Kreienberg R (2000) Classification of asymptomatic adnexal masses by ultrasound, magnetic resonance imaging, and positron emission tomography. Gynecol Oncol 77:454–459CrossRefPubMed
43.
go back to reference Nakamoto Y, Saga T, Ishimori T, Mamede M, Togashi K, Higuchi T, Mandai M, Fujii S, Sakahara H, Konishi J (2001) Clinical value of positron emission tomography with FDG for recurrent ovarian cancer. AJR Am J Roentgenol 176:1449–1454PubMed Nakamoto Y, Saga T, Ishimori T, Mamede M, Togashi K, Higuchi T, Mandai M, Fujii S, Sakahara H, Konishi J (2001) Clinical value of positron emission tomography with FDG for recurrent ovarian cancer. AJR Am J Roentgenol 176:1449–1454PubMed
44.
go back to reference Schroder W, Zimny M, Rudlowski C, Bull U, Rath W (1999) The role of 18F-fluoro-deoxyglucose positron emission tomography (18F-FDG-PET) in diagnosis of ovarian cancer. Int J Gynecol Cancer 9:117–122CrossRefPubMed Schroder W, Zimny M, Rudlowski C, Bull U, Rath W (1999) The role of 18F-fluoro-deoxyglucose positron emission tomography (18F-FDG-PET) in diagnosis of ovarian cancer. Int J Gynecol Cancer 9:117–122CrossRefPubMed
45.
go back to reference Ishiko O, Honda K, Hirai K, Sumi T, Ogita S, Koyama K, Kawabe J, Ochi H (2001) Diagnosis of metastases of ovarian clear cell carcinoma to the peritoneum of the abdominal wall by positron emission tomography with (fluorine-18)-2-deoxyglucose. Oncol Rep 8:67–69PubMed Ishiko O, Honda K, Hirai K, Sumi T, Ogita S, Koyama K, Kawabe J, Ochi H (2001) Diagnosis of metastases of ovarian clear cell carcinoma to the peritoneum of the abdominal wall by positron emission tomography with (fluorine-18)-2-deoxyglucose. Oncol Rep 8:67–69PubMed
46.
go back to reference Umesaki N, Tanaka T, Miyama M, Kawamura N, Ogita S, Kawabe J, Okamura T, Koyama K, Ochi H (2001) Positron emission tomography with (18)F-fluorodeoxyglucose of uterine sarcoma: a comparison with magnetic resonance imaging and power Doppler imaging. Gynecol Oncol 80:372–377CrossRefPubMed Umesaki N, Tanaka T, Miyama M, Kawamura N, Ogita S, Kawabe J, Okamura T, Koyama K, Ochi H (2001) Positron emission tomography with (18)F-fluorodeoxyglucose of uterine sarcoma: a comparison with magnetic resonance imaging and power Doppler imaging. Gynecol Oncol 80:372–377CrossRefPubMed
47.
go back to reference Machado MC, Cunha JE, Penteado S, Bacchella T, Jukemura J, Costa AC, Halpern-Salomon I (2000) Preoperative diagnosis of pancreatic leiomyosarcoma. Int J Pancreatol 28:97–100CrossRefPubMed Machado MC, Cunha JE, Penteado S, Bacchella T, Jukemura J, Costa AC, Halpern-Salomon I (2000) Preoperative diagnosis of pancreatic leiomyosarcoma. Int J Pancreatol 28:97–100CrossRefPubMed
48.
go back to reference Thurer RL, Thorsen A, Parker JA, Karp DD (2000) FDG imaging of a pulmonary artery sarcoma. Ann Thorac Surg 70:1414–1415CrossRefPubMed Thurer RL, Thorsen A, Parker JA, Karp DD (2000) FDG imaging of a pulmonary artery sarcoma. Ann Thorac Surg 70:1414–1415CrossRefPubMed
49.
go back to reference Babatasi G, Massetti M, Agostini D, Galateau F, Le Page O, Saloux E, Bhoyroo S, Grollier G, Potier JC, Khayat A (1998) Leiomyosarcoma of the heart and great vessels. Ann Cardiol Angeiol (Paris) 47:451–458 Babatasi G, Massetti M, Agostini D, Galateau F, Le Page O, Saloux E, Bhoyroo S, Grollier G, Potier JC, Khayat A (1998) Leiomyosarcoma of the heart and great vessels. Ann Cardiol Angeiol (Paris) 47:451–458
50.
go back to reference Beets G, Penninckx F, Schiepers C, Filez L, Mortelmans L, Kerremans R, Aerts R, De Roo M (1994) Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer. Br J Surg 81:1666–1670PubMed Beets G, Penninckx F, Schiepers C, Filez L, Mortelmans L, Kerremans R, Aerts R, De Roo M (1994) Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer. Br J Surg 81:1666–1670PubMed
51.
go back to reference Ak I, Stokkel MP, Pauwels EK (2000) Positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose in oncology. Part II. The clinical value in detecting and staging primary tumours. J Cancer Res Clin Oncol 126:560–574PubMed Ak I, Stokkel MP, Pauwels EK (2000) Positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose in oncology. Part II. The clinical value in detecting and staging primary tumours. J Cancer Res Clin Oncol 126:560–574PubMed
52.
go back to reference McDaniel KP, Charnsangavej C, DuBrow RA, Varma DG, Granfield CA, Curley SA (1993) Pathways of nodal metastasis in carcinomas of the cecum, ascending colon, and transverse colon: CT demonstration. AJR Am J Roentgenol 161:61–64 McDaniel KP, Charnsangavej C, DuBrow RA, Varma DG, Granfield CA, Curley SA (1993) Pathways of nodal metastasis in carcinomas of the cecum, ascending colon, and transverse colon: CT demonstration. AJR Am J Roentgenol 161:61–64
53.
go back to reference Turk PS, Wanebo HJ (1993) Results of surgical treatment of nonhepatic recurrence of colorectal carcinoma. Cancer 71[Suppl 12]:4267–4277 Turk PS, Wanebo HJ (1993) Results of surgical treatment of nonhepatic recurrence of colorectal carcinoma. Cancer 71[Suppl 12]:4267–4277
54.
go back to reference Greenway B (1988) Hepatic metastases from colorectal cancer: resection or not. Br J Surg 75:513–519PubMed Greenway B (1988) Hepatic metastases from colorectal cancer: resection or not. Br J Surg 75:513–519PubMed
55.
go back to reference Sugarbaker PH, Kemeny N (1989) Management of metastatic cancer to the liver. Adv Surg 22:1–56PubMed Sugarbaker PH, Kemeny N (1989) Management of metastatic cancer to the liver. Adv Surg 22:1–56PubMed
56.
go back to reference Bartolozzi C, Lencioni R, Donati F, Cioni D (2000) Abdominal MR: liver and pancreas. Syll. MRI – from basic knowledge to advanced strategies. Categorical Course European Congress of Radiology, March 5–10, Vienna. pp 121–137 Bartolozzi C, Lencioni R, Donati F, Cioni D (2000) Abdominal MR: liver and pancreas. Syll. MRI – from basic knowledge to advanced strategies. Categorical Course European Congress of Radiology, March 5–10, Vienna. pp 121–137
57.
go back to reference Itai Y, Matsui O (1997) Blood flow and liver imaging. Radiology 202:306–314PubMed Itai Y, Matsui O (1997) Blood flow and liver imaging. Radiology 202:306–314PubMed
59.
go back to reference Rummeny EJ, Marchal G (1997) Liver imaging: clinical applications and future perspectives. Acta Radiol 38:626–630PubMed Rummeny EJ, Marchal G (1997) Liver imaging: clinical applications and future perspectives. Acta Radiol 38:626–630PubMed
60.
go back to reference VanBeers BE, Gallezz B, Pringot J (1997) Contrast-enhanced MR-imaging of the liver. Radiology 203:297–306PubMed VanBeers BE, Gallezz B, Pringot J (1997) Contrast-enhanced MR-imaging of the liver. Radiology 203:297–306PubMed
Metadata
Title
Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors
Authors
B. Böhm
M. Voth
J. Geoghegan
H. Hellfritzsch
A. Petrovich
J. Scheele
D. Gottschild
Publication date
01-05-2004
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 5/2004
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-003-0527-6

Other articles of this Issue 5/2004

Journal of Cancer Research and Clinical Oncology 5/2004 Go to the issue